Diagnosis of anaplastic large-cell lymphoma in a dog using CD30 immunohistochemistry

Pittaway, R and Wu, Y and Suárez-Bonnet, A and Szladovits, B and Scurrell, E J and Garden, O A and Polton, G and Priestnall, S L (2018) Diagnosis of anaplastic large-cell lymphoma in a dog using CD30 immunohistochemistry. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION.

[img]
Preview
Text
11246.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Anaplastic large-cell lymphoma or null-cell lymphoma is a clinical entity reported in people, classified according to the unique appearance of large pleomorphic cells that express CD30. Null-cell lymphoma has also been described in dogs when neither CD3 nor CD79α is expressed by the tumor. We describe a case of lymphoma in the dog in which neoplastic cells did not express routine B- or T-lymphocyte markers on flow cytometry or immunohistochemistry; however, cells immunohistochemically labeled for CD30. The dog in our case died 5 mo after initial presentation, confirming a poor prognosis. Identification of further similar cases in dogs would provide additional prognostic information for this subset of lymphomas. CD30 may also serve as a potential therapeutic target in anaplastic large-cell lymphomas.